---
title: "Sastasundar Ventures (HEALTHX) Share Price, Financials & Research"
symbol: "HEALTHX"
company: "Sastasundar Ventures Ltd"
canonical: "https://tapetide.com/stocks/HEALTHX"
isin: "INE019J01013"
nse_symbol: "HEALTHX"
bse_code: "533259"
sector: "Healthcare Services"
industry: "Healthcare Service Provider"
generated_at: "2026-11-05T01:34:41.247Z"
---

# Sastasundar Ventures (HEALTHX)

Canonical page: https://tapetide.com/stocks/HEALTHX

## Key Facts

- **Price:** ₹270.80 as of 4 Nov 2026, 15:59 IST
- **P/E (TTM):** 33.06 as of 4 Nov 2026
- **1-year price change:** -9.29% from 4 Nov 2025 to 4 Nov 2026, adjusted for splits and bonuses, dividends excluded
- **Revenue, Dec 2025 quarter:** ₹345.74 Cr, against ₹281.29 Cr in Dec 2024 (+22.91% year on year)
- **Net profit, Dec 2025 quarter:** ₹0.37 Cr, against -₹37.80 Cr in Dec 2024
- **Promoter holding:** 74.07% in Sep 2026, unchanged from Jun 2026
- **Tapetide Score:** 36/100, Poor band as of 4 Nov 2026

## Company

- **NSE symbol:** HEALTHX
- **BSE code:** 533259
- **ISIN:** INE019J01013
- **Macro sector:** Healthcare
- **Sector:** Healthcare Services
- **Industry:** Healthcare Service Provider
- **In the F&O segment:** No

## Latest Price

- **Price:** ₹270.80
- **Change:** No trade today
- **Previous Close:** ₹270.80
- **As of:** 4 Nov 2026, 15:59 IST

## Key Fundamentals

Price-based figures as of 4 Nov 2026, 15:59 IST · EPS basis: Consolidated · TTM.

- **ROCE:** -1.33%
- **Debt to Equity:** 0.01
- **EPS (TTM):** ₹8.19
- **Book Value:** ₹201.47
- **P/E (TTM):** 33.06
- **P/B:** 1.34
- **ROE:** 4.63%
- **Dividend Yield:** 0.00%
- **EBITDA:** ₹6.20 Cr
- **52W High:** ₹363.00
- **52W Low:** ₹252.50

## Peer Comparison

Classification: Healthcare › Healthcare Services › Healthcare Service Provider

| Company | Price | P/E | Market Cap | P/B | Div Yield | ROE | ROCE | Sales TTM | Net Profit TTM |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| [Dr Lal Pathlabs Ltd (LALPATHLAB)](https://tapetide.com/stocks/LALPATHLAB) | ₹2,029.40 | 62.75 | ₹32,036 Cr | 13.58 | 0.26% | 22.30% | 28.00% | ₹2,891 Cr | ₹545 Cr |
| [Vijaya Diagnostic Centre Ltd (VIJAYA)](https://tapetide.com/stocks/VIJAYA) | ₹1,424.60 | 78.15 | ₹14,588 Cr | 15.33 | 0.14% | 18.30% | 20.50% | ₹857 Cr | ₹187 Cr |
| [Metropolis Healthcare Ltd (METROPOLIS)](https://tapetide.com/stocks/METROPOLIS) | ₹581.25 | 59.74 | ₹11,437 Cr | 8.03 | 0.88% | 13.60% | 17.80% | ₹1,710 Cr | ₹203 Cr |
| [Thyrocare Technologies Ltd (THYROCARE)](https://tapetide.com/stocks/THYROCARE) | ₹495.50 | 44.72 | ₹7,723 Cr | 14.25 | 2.90% | 28.40% | 35.40% | ₹876 Cr | ₹176 Cr |
| [Nephrocare Health Services Ltd (NEPHROPLUS)](https://tapetide.com/stocks/NEPHROPLUS) | ₹622.35 | 148.53 | ₹5,903 Cr | 5.61 | 0.00% | 8.83% | 15.30% | ₹1,053 Cr | ₹85 Cr |
| [Suraksha Diagnostic Ltd (SURAKSHA)](https://tapetide.com/stocks/SURAKSHA) | ₹333.05 | 48.41 | ₹1,717 Cr | 7.08 | 0.15% | 14.20% | 17.30% | ₹325 Cr | ₹35 Cr |
| [Krsnaa Diagnostics Ltd (KRSNAA)](https://tapetide.com/stocks/KRSNAA) | ₹483.05 | 15.84 | ₹1,571 Cr | 1.51 | 0.41% | 10.90% | 12.70% | ₹726 Cr | ₹98 Cr |
| [Sastasundar Ventures Ltd (HEALTHX)](https://tapetide.com/stocks/HEALTHX) (this company) | ₹270.80 | 33.06 | ₹903 Cr | 1.34 | 0.00% | 4.63% | -1.33% | ₹1,231 Cr | ₹29 Cr |
| Median of 8 companies | ₹538.38 | 54.08 | ₹6,813 Cr | 7.56 | 0.21% | 13.90% | 17.55% | ₹965 Cr | ₹137 Cr |

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

## Tapetide Score

Data-driven rating, 0–100, as of 4 Nov 2026.

- **Score:** 36/100 (Poor)
- **Data confidence:** 98/100

### Category scores

| Category | Score | Band | Weight | Measures |
| --- | ---: | --- | ---: | --- |
| Quality | 16 | Poor | 22% | Returns, margins, earnings quality |
| Valuation | 48 | Average | 24% | Cheap vs sector & own history |
| Growth | 33 | Poor | 9% | Sales & profit trajectory |
| Financial Health | 35 | Poor | 9% | Solvency, leverage, coverage |
| Momentum | 26 | Poor | 12% | Trend strength, vol-adjusted |
| Ownership | 51 | Average | 24% | FII/DII/promoter flows |

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

## Key Insights

### Strengths

- Company is almost debt free.
- Company has delivered good profit growth of 23.3% CAGR over last 5 years
- Company's median sales growth is 39.5% of last 10 years
- Company's working capital requirements have reduced from 66.1 days to 47.0 days

### Weaknesses

- Company has a low return on equity of -1.12% over last 3 years.
- Earnings include an other income of Rs.66.2 Cr.

## Technical Indicators

As of 4 Nov 2026.

| Group | Signal | Bearish | Neutral | Bullish |
| --- | --- | ---: | ---: | ---: |
| Overall | Strong Bearish | 11 | 7 | 1 |
| Oscillators | Neutral | 1 | 7 | 1 |
| Moving Averages | Strong Bearish | 10 | 0 | 0 |

### Oscillators: Neutral

| Name | Value | Signal |
| --- | ---: | --- |
| RSI (14) | 40.32 | Neutral |
| MACD (12,26,9) | -2.92 | Bullish |
| Stochastic (14,3,3) | 50.00 | Neutral |
| ADX (14) | 22.06 | Neutral |
| Williams %R (14) | -72.59 | Neutral |
| ATR (14) | 15.96 | Neutral |
| ROC (12) | -4.56 | Bearish |
| Stoch RSI (14) | 34.66 | Neutral |
| UO (7,14,28) | 40.16 | Neutral |

### Moving Averages: Strong Bearish

| Name | Value | Signal |
| --- | ---: | --- |
| SMA (10) | 276.72 | Bearish |
| EMA (10) | 278.89 | Bearish |
| SMA (20) | 280.34 | Bearish |
| EMA (20) | 280.58 | Bearish |
| SMA (50) | 288.89 | Bearish |
| EMA (50) | 287.31 | Bearish |
| SMA (100) | 300.42 | Bearish |
| EMA (100) | 292.41 | Bearish |
| SMA (200) | 293.72 | Bearish |
| EMA (200) | 293.09 | Bearish |

### Pivot Points

| Level | Classic | Fibonacci | Camarilla |
| --- | ---: | ---: | ---: |
| R3 | 303.79 | 296.87 | 276.29 |
| R2 | 296.87 | 289.25 | 274.46 |
| R1 | 283.84 | 284.54 | 272.63 |
| PP | 276.92 | 276.92 | 276.92 |
| S1 | 263.89 | 269.30 | 268.97 |
| S2 | 256.97 | 264.59 | 267.14 |
| S3 | 243.94 | 256.97 | 265.31 |

## Growth Rate

Growth computed from the financial statements below. A window with no rate gives the reason instead of a figure.

| Metric | Window | Growth | What it compares |
| --- | --- | ---: | --- |
| Revenue | 10Y | 36.4% | compounded annual rate, Mar 2015 to Mar 2025 |
| Revenue | 5Y | 24.47% | compounded annual rate, Mar 2020 to Mar 2025 |
| Revenue | 3Y | -13.62% | compounded annual rate, Mar 2022 to Mar 2025 |
| Revenue | 1Y | -19.06% | fiscal year to Mar 2025 vs the year to Mar 2024 |
| Revenue | TTM | 8.8% | four quarters to Dec 2025 vs the four to Dec 2024 |
| Net profit | 10Y | Loss widened | compounded annual rate, Mar 2015 to Mar 2025: -₹15.00 Cr to -₹134 Cr. A loss at both ends, larger at the end. |
| Net profit | 5Y | Loss widened | compounded annual rate, Mar 2020 to Mar 2025: -₹52.00 Cr to -₹134 Cr. A loss at both ends, larger at the end. |
| Net profit | 3Y | Turned to loss | compounded annual rate, Mar 2022 to Mar 2025: ₹865 Cr to -₹134 Cr. A profit at the start and a loss at the end. |
| Net profit | 1Y | Turned to loss | fiscal year to Mar 2025 vs the year to Mar 2024: ₹6.00 Cr to -₹134 Cr. A profit at the start and a loss at the end. |
| Net profit | TTM | Turned to profit | four quarters to Dec 2025 vs the four to Dec 2024: -₹130 Cr to ₹29.09 Cr. A loss at the start and a profit at the end. A growth rate off a loss has no meaning. |
| Operating cash flow | 10Y | Outflow widened | compounded annual rate, Mar 2015 to Mar 2025: -₹12.00 Cr to -₹17.00 Cr. A cash outflow at both ends, larger at the end. |
| Operating cash flow | 5Y | Outflow narrowed | compounded annual rate, Mar 2020 to Mar 2025: -₹69.00 Cr to -₹17.00 Cr. A cash outflow at the start, and a smaller one or none at the end. |
| Operating cash flow | 3Y | Outflow narrowed | compounded annual rate, Mar 2022 to Mar 2025: -₹207 Cr to -₹17.00 Cr. A cash outflow at the start, and a smaller one or none at the end. |
| Operating cash flow | 1Y | Turned negative | fiscal year to Mar 2025 vs the year to Mar 2024: ₹36.00 Cr to -₹17.00 Cr. A cash inflow at the start and an outflow at the end. |
| Operating cash flow | TTM | — | four quarters to Dec 2025 vs the four to Dec 2024. Reported once a year, so there is no trailing-twelve-month figure. |
| Operating margin | 10Y | +17.59 pp | compounded annual rate, Mar 2015 to Mar 2025 |
| Operating margin | 5Y | +11.76 pp | compounded annual rate, Mar 2020 to Mar 2025 |
| Operating margin | 3Y | -63.60 pp | compounded annual rate, Mar 2022 to Mar 2025 |
| Operating margin | 1Y | +0.04 pp | fiscal year to Mar 2025 vs the year to Mar 2024 |
| Operating margin | TTM | -0.57 pp | four quarters to Dec 2025 vs the four to Dec 2024 |

## Analyst Forecasts

Consensus of analyst estimates, as of 4 Nov 2026. Low and High are the range of the estimates, not a confidence interval.

### ROE (annual)

FY27 consensus: -13.0% (-12.8 pp vs -0.2% in FY26).

| Period | Mean | Low | High |
| --- | ---: | ---: | ---: |
| FY27 | -13.0% | -13.0% | -13.0% |

## Financial Statements

### Quarterly Results

Results for the period ended Mar 2026 were due by 30 May 2026 and are not in this table yet.

Figures in ₹ crore unless the row name gives another unit.

| Item | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Sales | 281 | 313 | 336 | 358 | 375 | 307 | 270 | 274 | 281 | 286 | 298 | 301 | 346 |
| Expenses | 291 | 324 | 327 | 355 | 371 | 317 | 273 | 278 | 305 | 311 | 292 | 324 | 356 |
| Operating Profit | -10.08 | -11.17 | 9.26 | 3.37 | 3.43 | -10.65 | -2.4 | -4.72 | -23.7 | -25.2 | 6.06 | -22.61 | -10.36 |
| OPM % | -3.59% | -3.57% | 2.76% | 0.94% | 0.92% | -3.47% | -0.89% | -1.73% | -8.43% | -8.82% | 2.03% | -7.5% | -3% |
| Other Income | 4.01 | 8.63 | 12.11 | 9.71 | 20.13 | 18.46 | 28.75 | -167 | -14.06 | 21.91 | 25.38 | 5.34 | 13.62 |
| Interest | 0.27 | 0.26 | 0.25 | 0.24 | 0.24 | 0.27 | 0.1 | 0.06 | 0.05 | 0.01 | 0.09 | 0.04 | 0.17 |
| Depreciation | 2.4 | 2.8 | 2.09 | 2.2 | 2.31 | 2.53 | 1.61 | 1.45 | 1.43 | 1.34 | 1.17 | 1.33 | 2.17 |
| Profit before tax | -8.74 | -5.6 | 19.03 | 10.64 | 21 | 5.01 | 24.64 | -174 | -39.24 | -4.64 | 30.18 | -18.64 | 0.92 |
| Tax % | -70.48% | 287.5% | -28.85% | -23.03% | 3.86% | -583.03% | -102.8% | -13.17% | 1.99% | -478.45% | 11.9% | -17.17% | 59.78% |
| Net Profit | -26.37 | -48 | -0.28 | -12.2 | -3.23 | 21.58 | 40.96 | -155 | -37.8 | 17.57 | 26.59 | -15.44 | 0.37 |
| EPS in Rs | -6 | -10.75 | 0.41 | -2.55 | -0.24 | 5.17 | 9.79 | -34.39 | -8.47 | 4.3 | 7.52 | -3.99 | 0.36 |

### Profit & Loss

Figures in ₹ crore unless the row name gives another unit.

| Item | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Sales | 30 | 52 | 89 | 135 | 162 | 222 | 388 | 551 | 1,798 | 1,060 | 1,432 | 1,159 | 1,231 |
| Expenses | 35 | 62 | 116 | 155 | 175 | 255 | 440 | 561 | 684 | 1,168 | 1,456 | 1,177 | 1,283 |
| Operating Profit | -4 | -10 | -28 | -20 | -13 | -33 | -52 | -10 | 1,114 | -107 | -24 | -19 | -52 |
| OPM % | -15% | -19% | -31% | -15% | -8% | -15% | -13% | -2% | 62% | -10% | -2% | -2% | -4% |
| Other Income | 0 | 2 | 0 | 2 | 7 | 0 | 1 | 1 | 3 | -5 | 4 | -179 | 66 |
| Interest | 1 | 1 | 2 | 3 | 1 | 3 | 1 | 3 | 3 | 2 | 1 | 0 | 0 |
| Depreciation | 2 | 6 | 7 | 7 | 6 | 6 | 5 | 4 | 4 | 8 | 9 | 6 | 6 |
| Profit before tax | -7 | -15 | -37 | -28 | -12 | -42 | -58 | -16 | 1,109 | -122 | -30 | -204 | 8 |
| Tax % | -5% | 0% | -1% | 2% | 19% | 3% | -9% | 4% | 22% | -19% | -119% | -34% | — |
| Net Profit | -6 | -15 | -37 | -29 | -15 | -43 | -52 | -17 | 865 | -99 | 6 | -134 | 29 |
| EPS in Rs | -2.03 | -4.68 | -11.51 | -9 | -3.73 | -11.81 | -12.19 | -3.27 | 197 | -22.7 | 2.79 | -28.66 | 8.19 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |

### Balance Sheet

Figures in ₹ crore unless the row name gives another unit.

| Item | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Equity Capital | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 |
| Reserves | 238 | 223 | 186 | 163 | 144 | 111 | 178 | 168 | 795 | 722 | 731 | 638 | 650 |
| Borrowings | 0 | 5 | 19 | 21 | 12 | 2 | 8 | 12 | 2 | 9 | 4 | 1 | 5 |
| Other Liabilities | 39 | 22 | 20 | 35 | 48 | 86 | 98 | 80 | 449 | 441 | 383 | 300 | 321 |
| Total Liabilities | 309 | 281 | 256 | 251 | 235 | 230 | 316 | 293 | 1,278 | 1,204 | 1,149 | 970 | 1,008 |
| Fixed Assets | 117 | 137 | 126 | 125 | 117 | 116 | 114 | 110 | 93 | 107 | 110 | 102 | 117 |
| CWIP | 0 | 3 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 10 | 1 |
| Investments | 41 | 22 | 10 | 17 | 46 | 36 | 56 | 43 | 666 | 513 | 676 | 575 | 633 |
| Other Assets | 151 | 119 | 120 | 110 | 71 | 77 | 146 | 139 | 518 | 583 | 363 | 283 | 257 |
| Total Assets | 309 | 281 | 256 | 251 | 235 | 230 | 316 | 293 | 1,278 | 1,204 | 1,149 | 970 | 1,008 |

### Cash Flow

Figures in ₹ crore unless the row name gives another unit.

| Item | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash from Operating Activity | 36 | -12 | -12 | -2 | -49 | -30 | -69 | -31 | -207 | -112 | 36 | -17 |
| Cash from Investing Activity | -42 | 7 | -1 | 4 | 15 | -2 | -22 | 21 | 220 | 133 | -34 | -1 |
| Cash from Financing Activity | -3 | 4 | 13 | 5 | 33 | 26 | 103 | 4 | -11 | -2 | -2 | 0 |
| Net Cash Flow | -10 | -1 | 0 | 7 | -2 | -6 | 11 | -5 | 1 | 19 | 0 | -19 |
| Free Cash Flow | 15 | -28 | -18 | 0 | -55 | -33 | -71 | -31 | -212 | -128 | 22 | -27 |
| CFO/OP | -845 | 106 | 43 | 17 | 377 | 89 | 133 | 288 | -8 | 104 | -172 | 68 |

### Ratios

| Item | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Debtor Days | 169 | 87 | 34 | 52 | 9 | 13 | 14 | 9 | 4 | 12 | 9 | 3 |
| Inventory Days | — | 337 | 91 | 80 | 73 | 59 | 77 | 57 | 71 | 69 | 34 | 40 |
| Days Payable | — | 165 | 38 | 69 | 24 | 26 | 50 | 29 | 21 | 22 | 13 | 21 |
| Cash Conversion Cycle | 169 | 259 | 87 | 62 | 58 | 46 | 41 | 38 | 55 | 59 | 31 | 22 |
| Working Capital Days | 441 | 344 | 182 | 49 | 61 | 61 | 54 | 44 | 46 | 93 | 58 | 47 |
| ROCE % | -2% | -6% | -14% | -12% | -8% | -19% | -25% | -6% | -7% | -11% | -3% | -1% |

## Shareholding Pattern

### Quarterly Shareholding

Holdings in % of shares; shareholders as a count.

| Holder | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Promoters | 74.43% | 74.43% | 74.43% | 73.72% | 73.72% | 73.92% | 73.92% | 73.92% | 73.92% | 73.92% | 73.92% | 73.92% | 73.92% | 73.92% | 73.92% | 73.94% | 74.11% | 74.24% | 74.24% | 74.69% | 74.84% | 74.07% | 74.07% |
| FIIs | 0.00% | 0.01% | 0.02% | 0.20% | 0.52% | 0.47% | 0.40% | 0.22% | 0.32% | 0.31% | 0.32% | 0.49% | 0.56% | 0.61% | 0.99% | 1.71% | 1.60% | 1.88% | 2.04% | 2.25% | 2.17% | 2.29% | 2.32% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.02% | 0.05% | 0.09% | 0.09% | 0.09% | 0.09% | 0.17% | 0.17% | 0.86% | 0.96% | 1.35% | 1.98% | 1.85% | 2.06% | 2.09% | 2.07% | 2.07% | 2.60% | 2.60% | 2.61% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 11.41% | 13.05% | 13.03% | 13.80% | 25.71% | 25.52% | 15.01% | 15.24% | 15.09% | 15.17% | 15.64% | 16.52% | 16.06% | 15.05% | 14.47% | 14.09% | 13.70% | 13.35% | 12.84% | 12.72% | 12.25% | 11.95% | 11.95% |
| Others | 14.16% | 12.52% | 12.55% | 12.48% | n/m | n/m | 10.98% | 10.76% | 10.90% | 10.74% | 9.95% | 8.20% | 8.51% | 9.07% | 8.63% | 8.41% | 8.52% | 8.44% | 8.81% | 8.27% | 8.15% | 9.09% | 9.04% |
| No. of Shareholders | 11,797 | 13,034 | 13,090 | 14,276 | 15,174 | 15,247 | 15,554 | 15,166 | 15,088 | 14,752 | 14,633 | 14,053 | 14,544 | 14,493 | 15,360 | 14,093 | 13,693 | 13,452 | 13,012 | 12,287 | 11,845 | 11,502 | 11,181 |

n/m: Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

## Documents

### Concalls

Latest 12 of 32.

| Month | Call documents |
| --- | --- |
| Aug 2026 | [PPT](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f48506bb-fff8-4084-8b6c-17c8fa93cea0.pdf) |
| Jun 2026 | [Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=207204e0-ce2a-47c4-a34e-37eec4f87736.pdf), [PPT](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5fb4420d-05df-4d16-ac5c-8285482e5d20.pdf), [Recording](http://healthxplatform.com/Audio/Analyst_Meet_Health_X_Platform_Ltd_%28earlier_Sastasundar_Ventures_Ltd%29_Recording_2.mp3) |
| Jun 2026 | [PPT](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6941cf6a-ff7f-4f3d-94fe-22890c6154e3.pdf) |
| Feb 2026 | [PPT](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=acde87eb-e98b-4ea3-b4d7-32470b948f8a.pdf) |
| Feb 2026 | [Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd3ff48d-d13b-4966-ba17-a2a443622da3.pdf), [PPT](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b2478904-59c6-459b-aec4-bcc310938568.pdf) |
| Nov 2025 | [Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8af28204-77c6-4a3d-8790-3a1fa7344d38.pdf), [PPT](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6ce373e6-ad1c-4b5d-97c7-754aa8ed710b.pdf) |
| Aug 2025 | [PPT](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9bed173d-d3d6-486e-8cf9-e48e476a31cf.pdf) |
| Jun 2025 | [Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=440d3301-6900-427a-a46a-80ef6a609290.pdf), [PPT](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=543ab431-2924-4075-9c82-c82659bb0922.pdf) |
| Feb 2025 | [PPT](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a23926c-29cc-4c70-be8e-27840e711ab7.pdf) |
| Nov 2024 | [Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=982ad4db-ceb7-4606-9c7e-f74d0efb639f.pdf), [PPT](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c879d941-87ac-43c7-a4fd-e3894b164028.pdf) |
| Oct 2024 | [PPT](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f562d3d5-d2c0-42f8-a4b3-9d8913f197b0.pdf) |
| Jun 2024 | [PPT](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0425b3a1-f2ec-4330-babc-6c141654fb27.pdf) |

### Results

Latest 12 of 33.

| Date | Document |
| --- | --- |
| 7 Aug 2026 | [Results - Unaudited Financial Results For The Quarter Ended 30Th June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d19ef00e-026a-4f85-a0e4-3ace88e52e57.pdf) |
| 30 May 2026 | [Results - Financial Results For The Quarter And Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7888f215-5b3a-4a1c-ac0d-f6bae66c06a6.pdf) |
| 6 Feb 2026 | [Results - Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=799764b1-2bc2-4e4f-9d26-0c64e8ffdaa4.pdf) |
| 13 Nov 2025 | [Results - Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30Th September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b5e6120e-32d2-4b63-afc2-a26a94de72ad.pdf) |
| 12 Aug 2025 | [Results - Unaudited Financial Results Standalone And Consolidated For The Quarter Ended 30Th June 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2ae3bb4-d155-4b7c-9159-bc24db6048a3.pdf) |
| 30 May 2025 | [Results - Audited Financial Results As On 31St March 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c2236ea3-6e2f-4790-b5e2-ca2713fe4f69.pdf) |
| 14 Feb 2025 | [Results - Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=312dfec9-a0e2-47d5-8734-ffd50519052e.pdf) |
| 14 Nov 2024 | [Results - Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac503b38-0242-4576-abfa-0c18887916ec.pdf) |
| 29 Jul 2024 | [Results - Unaudited Financial Results For The Quarter Ended June 30, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9bdd1c21-ab4b-48d8-8269-2a8d18086e5f.pdf) |
| 30 May 2024 | [Results - Financial Results For The Quarter And Financial Year Ended 31St March 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b247b040-f016-49c1-886e-e9dfdcff79db.pdf) |
| 31 Jan 2024 | [Results - Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended 31St December, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1940d520-f5cd-40e9-a586-e0379ea36acd.pdf) |
| 10 Nov 2023 | [Results - Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4391b0b8-5e64-45da-a70f-f9713d320e2f.pdf) |

### Annual reports

Latest 12 of 14.

| Year | Report |
| --- | --- |
| FY2025 | [Annual report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07434f13-418d-4db6-bb03-f2d2a6dcf515.pdf) |
| FY2024 | [Annual report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=79a73ef8-b5b2-4d7e-b734-86bc22d4540a.pdf) |
| FY2023 | [Annual report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe44cfe6-7cb3-45df-ab98-d816f120da72.pdf) |
| FY2022 | [Annual report](https://www.bseindia.com/bseplus/AnnualReport/533259/76611533259.pdf) |
| FY2021 | [Annual report](https://www.bseindia.com/bseplus/AnnualReport/533259/71176533259.pdf) |
| FY2020 | [Annual report](https://www.bseindia.com/bseplus/AnnualReport/533259/5332590320.pdf) |
| FY2019 | [Annual report](https://www.bseindia.com/bseplus/AnnualReport/533259/5332590319.pdf) |
| FY2018 | [Annual report](https://www.bseindia.com/bseplus/AnnualReport/533259/5332590318.pdf) |
| FY2017 | [Annual report](https://www.bseindia.com/bseplus/AnnualReport/533259/5332590317.pdf) |
| FY2016 | [Annual report](https://www.bseindia.com/bseplus/AnnualReport/533259/5332590316.pdf) |
| FY2015 | [Annual report](https://www.bseindia.com/bseplus/AnnualReport/533259/5332590315.pdf) |
| FY2014 | [Annual report](https://www.bseindia.com/bseplus/AnnualReport/533259/5332590314.pdf) |

### Exchange filings

Latest 12 of 77.

| Date | Document | Category |
| --- | --- | --- |
| 9 Oct 2026 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=021898df-c361-487e-93f5-dad3afaef5c1.pdf) | General announcements |
| 29 Sep 2026 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d3f53ac6-e43f-46dd-b845-e5d3fe6c57c7.pdf) | Outcome |
| 29 Sep 2026 | [Disclosure Of Voting Results Of The 37Th AGM Of The Company In Terms Of Regulation 44 Of The SEBI (Listing Obligations And Disclosure Requirements) Reg 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fdf0bf5b-15a1-4a62-b973-93a6ca4186d9.pdf) | General announcements |
| 28 Sep 2026 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c31722f-0061-4699-9cc8-2bb71c504e8c.pdf) | Outcome |
| 25 Sep 2026 | [Closure of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=55b1d4c6-9aab-4178-87d7-b14b5a566b3e.pdf) | Intimation |
| 5 Sep 2026 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c71cd545-c185-4468-bf75-f81251ae7f5f.pdf) | General announcements |
| 4 Sep 2026 | [Notice Of The 37Th Annual General Meeting Of The Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0c17785-30f1-4d5f-9903-13e88817f75a.pdf) | Intimation |
| 4 Sep 2026 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=805d3c77-f482-47c9-947c-a745a671c4c9.pdf) | General announcements |
| 4 Sep 2026 | [Business Responsibility and Sustainability Reporting (BRSR)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d355e249-58af-4758-a06c-bc077bc6a6de.pdf) | General announcements |
| 4 Sep 2026 | [Dispatch Of Letter To Shareholders Whose E-Mail Addresses Are Not Registered With The Company Or RTA Or Depository Participants](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=84be14e8-3dd7-4896-b2cf-0568469af034.pdf) | General announcements |
| 1 Sep 2026 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5fa65cb8-38ca-4f67-a4c4-da06bf6ce772.pdf) | General announcements |
| 31 Aug 2026 | [Intimation Regarding The 37Th Annual General Meeting Of The Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c7e63b18-906e-41f0-ac58-9b1352f6da2c.pdf) | General announcements |

## Frequently Asked Questions about Health X Platform

### What does Sastasundar Ventures Ltd do?

Incorporated in 1989, Sastasundar Ventures Ltd is in the business of digital network of healthcare and portfolio management services

### Where is Sastasundar Ventures Ltd (HEALTHX) listed?

Sastasundar Ventures Ltd trades as HEALTHX on the NSE and under code 533259 on the BSE.

### Which sector does Sastasundar Ventures Ltd belong to?

Sastasundar Ventures Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.

### What is the PE ratio of Sastasundar Ventures Ltd?

Sastasundar Ventures Ltd trades at a PE ratio of 33.06 as of 4 Nov 2026, on earnings per share of ₹8.19, against a book value of ₹201.47 per share.

### What is the 52-week high and low of Sastasundar Ventures Ltd?

Over the last 52 weeks Sastasundar Ventures Ltd has traded between ₹252.5 and ₹363 as of 4 Nov 2026.

### What is the Return on Equity (ROE) of Sastasundar Ventures Ltd?

Sastasundar Ventures Ltd reported a return on equity of 4.63%. Its debt-to-equity ratio is 0.01.

## Company Information

Incorporated in 1989, Sastasundar Ventures Ltd is in the business of digital network of healthcare and portfolio management services

- **Website:** https://sastasundarventures.com/
- **CEO:** Mr. Banwari Lal Mittal
- **Employees:** 1,657
- **Listed:** 5 Oct 2010
- **Face Value:** ₹10

---

Negative figures use an ASCII hyphen-minus (-) so they parse as numbers. Amounts are in Indian rupees; "Cr" is crore (10 million). Dates are Indian Standard Time.

Financial statements, shareholding and filings are as reported by the company. Price, volume and 52-week levels are market data. Technical indicators are computed by Tapetide from daily prices. The Tapetide Score is Tapetide’s own analysis. Analyst ratings and forecasts are the published estimates of third-party analysts, not company statements. The AI sections are generated text.

For research and information only, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Generated 5 Nov 2026, 07:04 IST.